Sunday - June 2, 2024

Azithromycin and Roxithromycin Derivatives as Senolytic Drugs

2024-04-16

ALEXANDRIA, Virginia, April 16 -- LUNELLA BIOTECH, INC., Ontario, Canada has been assigned a patent (No. US 11957700 B2, initially filed Oct. 2, 2019) developed by Federica Sotgia, Fulton, Maryland, and Michael P. Lisanti, Fulton, Maryland, for "Azithromycin and roxithromycin derivatives as senolytic drugs." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Azithromycin and Roxithromycin Derivatives as Senolytic Drugs

Information Request Form

Copyright Targeted News Service 2024